Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
18204501000001116 | Redoxon 500mg modified-release capsules (Bayer Plc) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
18204601000001117 | Redoxon 500mg modified-release capsules (Bayer Plc) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Redoxon 500mg modified-release capsules (Bayer Plc) 20 capsule 2 x 10 capsules | Is pack of | False | Redoxon 500mg modified-release capsules (Bayer Plc) | Inferred relationship | Existential restriction modifier | |
Redoxon 500mg modified-release capsules (Bayer Plc) 40 capsule 4 x 10 capsules | Is pack of | False | Redoxon 500mg modified-release capsules (Bayer Plc) | Inferred relationship | Existential restriction modifier | |
Redoxon 500mg modified-release capsules (Bayer Plc) 40 capsule 4 x 10 capsules | Has AMP | True | Redoxon 500mg modified-release capsules (Bayer Plc) | Inferred relationship | Existential restriction modifier | |
Redoxon 500mg modified-release capsules (Bayer Plc) 20 capsule 2 x 10 capsules | Has AMP | True | Redoxon 500mg modified-release capsules (Bayer Plc) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets